Barings LLC Amgen Inc Transaction History

Barings LLC

$4.08 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $112,224 - $142,594	-490 Reduced 25.74%	1,414 $371,000
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $716,925 - $808,561	-3,194 Reduced 62.65%	1,904 $429,000
Q2 2022 Aug 08, 2022	BUY	$230.71 - $256.74 $698,589 - $777,408	3,028 Added 146.28%	5,098 $1.24 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $395,782 - $437,838	-1,805 Reduced 46.58%	2,070 $500,000
Q4 2021 Feb 09, 2022	BUY	$198.88 - $227.6 $113,361 - $129,732	570 Added 17.25%	3,875 $872,000
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $265,549 - $311,123	-1,251 Reduced 27.46%	3,305 $703,000
Q2 2021 Aug 11, 2021	SELL	$233.58 - $259.14 $79,417 - $88,107	-340 Reduced 6.94%	4,556 $1.11 Million
Q1 2021 May 11, 2021	SELL	$221.91 - $258.6 $59,249 - $69,046	-267 Reduced 5.17%	4,896 $1.22 Million
Q4 2020 Feb 16, 2021	SELL	$216.38 - $257.67 $8.64 Million - $10.3 Million	-39,947 Reduced 88.55%	5,163 $1.19 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $658,662 - $732,486	-2,807 Reduced 5.86%	45,110 $11.5 Million
Q1 2020 May 15, 2020	BUY	$182.24 - $241.7 $227,800 - $302,125	1,250 Added 2.68%	47,917 $9.71 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $996,190 - $1.28 Million	5,265 Added 12.72%	46,667 $11.3 Million
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $316,357 - $379,062	1,817 Added 4.59%	41,402 $8.01 Million
Q2 2019 Aug 12, 2019	SELL	$166.7 - $195.41 $4.92 Million - $5.76 Million	-29,498 Reduced 42.7%	39,585 $7.29 Million
Q1 2019 May 08, 2019	BUY	$180.87 - $203.88 $1.55 Million - $1.75 Million	8,588 Added 14.2%	69,083 $13.1 Million
Q4 2018 Feb 07, 2019	SELL	$178.4 - $208.25 $11.3 Million - $13.2 Million	-63,202 Reduced 51.09%	60,495 $11.8 Million
Q3 2018 Oct 26, 2018	BUY	$185.29 - $208.89 $6.85 Million - $7.72 Million	36,965 Added 42.62%	123,697 $25.6 Million
Q2 2018 Aug 03, 2018	BUY	$166.05 - $186.51 $2.11 Million - $2.37 Million	12,691 Added 17.14%	86,732 $16 Million
Q1 2018 May 04, 2018	SELL	$169.43 - $198.0 $525,233 - $613,800	-3,100 Reduced 4.02%	74,041 $12.6 Million
Q4 2017 Feb 08, 2018	BUY	$168.79 - $188.59 $6.83 Million - $7.63 Million	40,435 Added 110.16%	77,141 $13.4 Million
Q3 2017 Nov 13, 2017	SELL	$167.29 - $191.0 $2.1 Million - $2.4 Million	-12,580 Reduced 25.52%	36,706 $6.84 Million
Q2 2017 Aug 15, 2017	SELL	N/A	-27,013 Reduced 35.4%	49,286 $8.49 Million
Q2 2017 Aug 14, 2017	BUY	N/A	76,299	76,299 $0

Others Institutions Holding AMGN

# of Institutions

3,075

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Barings LLC with notifications on news.

Account